Engl Julia, Bobbert Thomas, Ciardi Christian, Laimer Markus, Tatarczyk Tobias, Kaser Susanne, Weiss Helmut, Molnar Clemens, Tilg Herbert, Patsch Josef R, Spranger Joachim, Ebenbichler Christoph F
Department of Internal Medicine, Clinical Division of General Internal Medicine, Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
Obesity (Silver Spring). 2007 May;15(5):1172-8. doi: 10.1038/oby.2007.627.
Adiponectin is an adipocytokine secreted into circulation in three isoforms. The aim of the study was to investigate changes of adiponectin isoforms during profound weight loss and its relation to anthropomorphometric and metabolic parameters.
Thirteen severely obese female subjects were examined before and 1 year after surgical treatment. Total adiponectin was determined by radioimmunosorbent assay, and oligomer composition was detected by nondenaturing Western blot.
BMI decreased substantially (p < 0.001), which was associated with an increase of total adiponectin from 12.9 +/- 5.9 to 14.3 +/- 6.1 microg/mL (p = 0.055). Medium molecular weight (MMW) adiponectin increased from 7.5 +/- 3.6 to 9.1 +/- 4.1 microg/mL (p = 0.009), whereas high (HMW) and low molecular weight adiponectin remained unchanged. Delta values of total adiponectin correlated significantly with Delta values of anthropometric parameters. Similar correlations were found for Delta values of MMW (Delta weight: r(2) = 0.4132, p = 0.0178; Delta BMI: r(2) = 0.3319, p = 0.0393; Delta fat mass: r(2) = 0.5202, p = 0.0054).
Thus, profound weight loss was associated with an increase in total adiponectin, which was mainly and consistently caused by increases in MMW adiponectin (p = 0.009). These changes result in a shift from low molecular weight to MMW and HMW adiponectin isoforms, which may be related to improvements in both anthropometric and metabolic parameters.
脂联素是一种以三种异构体形式分泌进入循环系统的脂肪细胞因子。本研究旨在探讨深度体重减轻过程中脂联素异构体的变化及其与人体测量学和代谢参数的关系。
对13名严重肥胖女性受试者在手术治疗前和治疗后1年进行检查。通过放射免疫吸附测定法测定总脂联素,并通过非变性蛋白质免疫印迹法检测寡聚体组成。
体重指数(BMI)显著下降(p < 0.001),这与总脂联素从12.9±5.9微克/毫升增加到14.3±6.1微克/毫升相关(p = 0.055)。中分子量(MMW)脂联素从7.5±3.6微克/毫升增加到9.1±4.1微克/毫升(p = 0.009),而高分子量(HMW)和低分子量脂联素保持不变。总脂联素的变化值与人体测量学参数的变化值显著相关。MMW变化值也有类似的相关性(体重变化:r(2) = 0.4132, p = 0.0178;BMI变化:r(2) = 0.3319, p = 0.0393;脂肪量变化:r(2) = 0.5202, p = 0.0054)。
因此,深度体重减轻与总脂联素增加相关,这主要且持续是由MMW脂联素增加所致(p = 0.009)。这些变化导致从低分子量脂联素异构体向MMW和HMW脂联素异构体转变,这可能与人体测量学和代谢参数的改善有关。